Advances and Challenges in Treatment De-Intensification of HPV-Associated Oropharyngeal Squamous Cell Carcinoma

被引:0
|
作者
Cao, Yilin [1 ]
Gilbert, Richard J. [4 ]
Quon, Harry [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, 401 North Broadway,Suite 1440, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, 401 North Broadway,Suite 1440, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Dept Oncol, 401 North Broadway,Suite 1440, Baltimore, MD 21287 USA
[4] Brown Univ, Dept Pathol & Lab Med, Warren Alpert Med Sch, Providence, RI 02912 USA
关键词
Human papillomavirus; Oropharyngeal carcinoma; Cancer treatment morbidity and mortality; Treatment de-intensification; Radiotherapy dose de-escalation; Swallow toxicity assessment; QUALITY-OF-LIFE; NECK-CANCER PATIENTS; HUMAN-PAPILLOMAVIRUS; RADIATION-THERAPY; HEAD; TRIAL; QUESTIONNAIRE; CHEMOTHERAPY; RADIOTHERAPY; VALIDATION;
D O I
10.1007/s40136-022-00425-2
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose of Review Management paradigms for oropharyngeal carcinoma (OPC) have been rapidly evolving due to the recognition that cancers associated with the human papillomavirus (HPV) have a favorable prognosis. This is especially the case with radiation therapy as a principal curative modality, as it is associated with a number of significant treatment complications due to the anatomic density of the head and neck and the importance of the oropharyngeal organs in swallow function. This has consequently raised major questions as to whether management can be fundamentally de-intensified in terms of dose and volume, and thereby reduce injury to the surrounding normal tissue. Recent Findings Several phase I/II clinical trials have supported the hypothesis that early stage HPV-OPC can be effectively treated with de-intensified therapies from an oncologic perspective, although there remain many unanswered questions regarding the optimal de-escalation strategy from a toxicity perspective. Confounding these efforts remains our inability to quantify normal tissue injury and its relationship to swallow function. To date, existing tools largely quantify the degree of swallow injury with varying degrees of reproducibility and granularity. Analyses of the relationship between radiation dose and swallow outcomes have also typically been limited to the dose delivered to isolated normal structures and have not considered spatial radiation dose to the complex "systems" of organs that govern swallow function. Treatment de-intensification for HPV-associated OPC represents a rapidly advancing field where early studies suggest that oncologic efficacy for early stage cancers may not be compromised with lower radiation dose and minimally invasive surgical techniques. Generalizing this conclusion remains limited by the number of patients evaluated in clinical trials. The ability to determine if these efforts are reducing normal tissue injury and swallow function is also limited by the existing instruments used to measure injury.
引用
收藏
页码:464 / 474
页数:11
相关论文
共 50 条
  • [21] Oropharyngeal squamous cell carcinoma: Treatment (de-) intensification?
    Pace, Gian Marco
    Costantino, Andrea
    Festa, Bianca Maria
    Spriano, Giuseppe
    Bussu, Francesco
    Pellini, Raul
    De Virgilio, Armando
    ORAL ONCOLOGY, 2024, 153
  • [22] Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma
    De Virgilio, Armando
    Costantino, Andrea
    Mercante, Giuseppe
    Petruzzi, Gerardo
    Sebastiani, Daniela
    Franzese, Ciro
    Scorsetti, Marta
    Pellini, Raul
    Malvezzi, Luca
    Spriano, Giuseppe
    CURRENT ONCOLOGY REPORTS, 2020, 22 (09)
  • [23] Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma
    Armando De Virgilio
    Andrea Costantino
    Giuseppe Mercante
    Gerardo Petruzzi
    Daniela Sebastiani
    Ciro Franzese
    Marta Scorsetti
    Raul Pellini
    Luca Malvezzi
    Giuseppe Spriano
    Current Oncology Reports, 2020, 22
  • [24] Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Habib, Andy M.
    Carey, Ryan M.
    Prasad, Aman
    Mady, Leila J.
    Shinn, Justin R.
    Bur, Andres M.
    Brody, Robert M.
    Cannady, Steven B.
    Rajasekaran, Karthik
    Ibrahim, Said A.
    Newman, Jason G.
    Brant, Jason A.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 166 (06) : 1062 - 1069
  • [25] Triweekly carboplatin as a potential de-intensification agent in concurrent chemoradiation for early-stage HPV-associated oropharyngeal cancer
    Iganej, Shawn
    Beard, Bryce W.
    Chen, Jergin
    Buchschacher, Gary L., Jr.
    Abdalla, Iman A.
    Thompson, Lester D. R.
    Bhattasali, Onita
    ORAL ONCOLOGY, 2019, 97 : 18 - 22
  • [26] The human palatine tonsil microbiome in HPV-associated oropharyngeal squamous cell carcinoma
    De Martin, A.
    Lutge, M.
    Engetschwiler, C.
    Dappen, M. Broglie
    Stockli, S.
    McCoy, K.
    Ludewig, B.
    SWISS MEDICAL WEEKLY, 2019, : 26S - 26S
  • [27] Ultrasound Guided Biopsy in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Haller, Travis J.
    Van Abel, Kathryn M.
    Yin, Linda X.
    Lohse, Christine M.
    Douse, Dontre'
    Badaoui, Joseph N.
    Price, Daniel L.
    Kasperbauer, Jan L.
    Moore, Eric J.
    LARYNGOSCOPE, 2022, 132 (12): : 2396 - 2402
  • [28] Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer
    Muniz, Isis de Araujo Ferreira
    Araujo, Megan
    Bouassaly, Jenna
    Farshadi, Fatemeh
    Atique, Mai
    Esfahani, Khashayar
    Bonan, Paulo Rogerio Ferreti
    Hier, Michael
    Mascarella, Marco
    Mlynarek, Alex
    Alaoui-Jamali, Moulay
    da Silva, Sabrina Daniela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [29] Diagnostic Accuracy of FNA to Determine HPV Status in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Morse, R.
    Beaty, B.
    Scanga, L.
    Blumberg, J.
    Patel, S.
    Shen, C.
    Chera, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E31 - E32
  • [30] Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma
    Morse, Ryan T.
    Beaty, Brian
    Scanga, Lori
    Blumberg, Jeff
    Patel, Samip
    Yarbrough, Wendell G.
    Lumley, Catherine
    Hackman, Trevor
    Shen, Colette
    Gupta, Gaorav P.
    Chera, Bhisham S.
    ORAL ONCOLOGY, 2022, 134